ALLO
Allogene Therapeutics, Inc.1.91post+$0.01 (+0.53%)at close +$0.00 (+0.00%)
as of 08:00:03 UTCnext report Aug 10 · 5d
Earnings Room‹ back to ALLO
The report
fiscal Q2 2026 · from the company's noticeAug 10after close5days out
Expected movement
market-implied · at the Aug 4 close±15.6%is what the chain prices between now and the expiry below. Not a view we hold.
That span is 17days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.
expiry Aug 21 · first after the reportATM strike 2straddle 0.35ATM IV 102%× 0.85 straddle-to-rangespot 1.91
Blast radius
3 linked · N-PORT + EDGARIf ALLO moves ±15.6% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
Butterfly LadderNo options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.
The record
expected in pale · actual in full color0/8reports moved further than the options market had pricedtypically ±6.6% realized vs ±24.4% priced
May 13 '26±14.0%→−8.2%×0.58
Mar 12 '26±33.1%→−2.8%×0.09
Nov 6 '25±23.5%→+12.4%×0.53
Aug 13 '25±39.7%→+2.9%×0.07
May 13 '25±21.3%→−15.7%×0.74
Mar 13 '25±23.8%→+2.6%×0.11
Nov 7 '24±25.2%→−3.5%×0.14
Aug 7 '24±14.9%→−4.5%×0.30
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported -0.18 · rev $0
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.